CM Kramm

Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene.

Efstathios Boviatsis, Jungsun Park, Miguel Sena‐Esteves et al. · PubMed · 1994 · 177 citations

Medicine, Oncology, Pharmacology +15

Vaccination for experimental gliomas using GM-CSF-transduced glioma cells.

Ulrich Herrlinger, CM Kramm, Karen M. Johnston et al. · PubMed · 1998 · 110 citations

Medicine, Neuroscience, Oncology +14

Pre-existing herpes simplex virus 1 (HSV-1) immunity decreases, but does not abolish, gene transfer to experimental brain tumors by a HSV-1 vector

Ulrich Herrlinger, CM Kramm, K S. Aboody-Guterman et al. · Gene Therapy · 1998 · 81 citations

Life Sciences, Immunology, Neuroscience +13

Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm.

N. G. Rainov, CM Kramm, K S. Aboody-Guterman et al. · PubMed · 1996 · 48 citations

Medicine, Neuroscience, Oncology +16